Interstrand cross-linking of DNA by FK317 and its deacetylated metabolites FR70496 and FR157471.
Interstrand cross-linking of DNA by FK317 and its deacetylated metabolites FR70496 and FR157471.
复制标题
FK317 及其脱乙酰代谢物 FR70496 和 FR157471 进行的 DNA 链间交联。
DOI:
10.1021/bi035202x
复制
发表时间:
2003
期刊:
影响因子:
2.9
通讯作者:
Ducept,Pascal
中科院分区:
文献类型:
--
作者:
Williams,RobertM;Ducept,Pascal
FR900482 (1) and FR66979 (2) are structurally novel natural products isolated by Fujisawa in 1987 and have been shown to be highly potent antitumor antibiotics structurally related to the mitomycins. Studies on the mode of action have established that these new agents form covalent DNA interstrand cross-links bothin vitroandin vivoas a result of the reactive mitosene intermediate generated upon bioreductive activation. Semisynthetic analogues such as FK973 (3) and FK317 (4) were developed in the search for potentially superior clinical candidates. Although FK317 has been shown to be a potent compound, to date no direct evidence of DNA interstrand cross-link sequence specificity has been reported. In this study, DNA interstrand cross-links were generated by treatment of a synthetic duplex DNA substrate with FK317 (4) and its deacetylated metabolites FR70496 (5) and FR157471 (6). Analysis by gel electrophoresis revealed the formation of orientation isomers displaying electrophoretic mobility vastly greater than the mobilities of those generated from FR900482 (1). Despite these differences, it was established by Fe(II)−EDTA footprinting that FK317 (4) as well as5and6forms DNA interstrand cross-links within the expected 5‘CpG3‘ step, clearly demonstrating that the phenolic hydrogen in1and2is not a prerequisite for efficient DNA interstrand cross-linking by the FR class of compounds.